日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Associations of TNFRSF10A with Central Serous Chorioretinopathy, Polypoidal Choroidal Vasculopathy, and Age-Related Macular Degeneration

TNFRSF10A与中心性浆液性脉络膜视网膜病变、息肉状脉络膜血管病变和年龄相关性黄斑变性的关联

Chen, Zhen Ji; Yu, Jun; Ng, Danny S C; Ho, Mary; Zhu, Xintian; Brelen, Marten E; Young, Alvin L; Yam, Jason C; Tham, Clement C; Pang, Chi Pui; Chen, Li Jia

Integrating AI/ML and multi-omics approaches to investigate the role of TNFRSF10A/TRAILR1 and its potential targets in pancreatic cancer

整合人工智能/机器学习和多组学方法,研究TNFRSF10A/TRAILR1及其潜在靶点在胰腺癌中的作用

Sharma, Sudhanshu; Singh, Rajesh; Kant, Shiva; Mishra, Manoj K

LncRNA TNFRSF10A-AS1 promotes gastric cancer by directly binding to oncogenic MPZL1 and is associated with patient outcome

lncRNA TNFRSF10A-AS1通过直接结合致癌基因MPZL1促进胃癌的发生发展,并与患者预后相关。

Sun, Donglei; Gou, Hongyan; Wang, Dandan; Li, Chenyang; Li, Yan; Su, Hao; Wang, Xiaohong; Zhang, Xiaolan; Yu, Jun

Induction of apoptotic cell death in human bladder cancer cells by ethanol extract of Zanthoxylum schinifolium leaf, through ROS-dependent inactivation of the PI3K/Akt signaling pathway

花椒叶乙醇提取物通过 ROS 依赖性 PI3K/Akt 信号通路失活诱导人膀胱癌细胞凋亡

Cheol Park, Eun Ok Choi, Hyun Hwangbo, Hyesook Lee, Jin-Woo Jeong, Min Ho Han, Sung-Kwon Moon, Seok Joong Yun, Wun-Jae Kim, Gi-Young Kim, Hye-Jin Hwang, Yung Hyun Choi

Anti-EGFR VHH-armed death receptor ligand-engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers

抗EGFR VHH武装的死亡受体配体工程化异体干细胞对多种脑转移性乳腺癌具有治疗效果。

Yohei Kitamura ,Nobuhiko Kanaya ,Susana Moleirinho ,Wanlu Du ,Clemens Reinshagen ,Nada Attia ,Agnieszka Bronisz ,Esther Revai Lechtich ,Hikaru Sasaki ,Joana Liliana Mora ,Priscilla Kaliopi Brastianos ,Jefferey L Falcone ,Aldebaran M Hofer ,Arnaldo Franco ,Khalid Shah

Poly(beta-amino ester) nanoparticles enable tumor-specific TRAIL secretion and a bystander effect to treat liver cancer

聚(β-氨基酯)纳米颗粒可诱导肿瘤特异性TRAIL分泌,并产生旁观者效应,从而用于治疗肝癌。

Hannah J Vaughan ,Camila G Zamboni ,Nicholas P Radant ,Pranshu Bhardwaj ,Esther Revai Lechtich ,Laboni F Hassan ,Khalid Shah ,Jordan J Green

Recombinant protein TRAIL-Mu3 enhances the antitumor effects in pancreatic cancer cells by strengthening the apoptotic signaling pathway

重组蛋白TRAIL-Mu3通过增强凋亡信号通路增强胰腺癌细胞的抗肿瘤作用

Min Huang, Cheng Yi, Xian-Zhou Huang, Juan Yan, Li-Jia Wei, Wei-Ju Tang, Shou-Chun Chen, Ying Huang

Enhancing radiation response by a second-generation TRAIL receptor agonist using a new in vitro organoid model system

使用新的体外类器官模型系统增强第二代 TRAIL 受体激动剂的放射反应

Shuraila F Zerp, Zainab Bibi, Inge Verbrugge, Emile E Voest, Marcel Verheij

Treatment with Soluble Activin Receptor Type IIB Alters Metabolic Response in Chemotherapy-Induced Cachexia

可溶性活化素受体 IIB 型治疗可改变化疗引起的恶病质的代谢反应

Thomas M O'Connell, Fabrizio Pin, Marion E Couch, Andrea Bonetto

Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL)

葡萄球菌核酸酶和Tudor结构域1(SND1蛋白)通过抑制单甘油酯脂肪酶(MGLL)促进肝癌发生

Devaraja Rajasekaran, Nidhi Jariwala, Rachel G Mendoza, Chadia L Robertson, Maaged A Akiel, Mikhail Dozmorov, Paul B Fisher, Devanand Sarkar